Who
Michael G. Atieh
Director
Company insider
Files Form 4 as: Director, Immatics; Director, Chubb; Director, Oyster Point Pharma; Director, electroCore; EVP, CFO, & CBO, Treasurer, Ophthotech; Director, Theravance Biopharma; Exec. VP & CFO, Osi Pharmaceuticals.
In numbers
- Trades disclosed
- 144
- Buys
- 0
- Sells
- 23
- Bought
- $0
- Sold
- $8.0M
- Companies
- 7
- Companies where not an officer
- 5
- First trade
- 18 May 2006
- Last trade
- 16 Jun 2026
- Last filed
- 18 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jun 2026filed 18 Jun 2026 | IMTX Immaticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —48,000 at $0.00 | filing |
| 16 Jun 2026filed 18 Jun 2026 | IMTX Immaticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —48,000 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | CB ChubbInsurance | SEC FORM 4 Code A | —681 | filing |
| 21 May 2026filed 26 May 2026 | CB ChubbInsurance | SEC FORM 4 Code F | $64K193 at $330.26 | filing |
| 21 May 2026filed 26 May 2026 | CB ChubbInsurance | SEC FORM 4 Sold | $190K578 at $329.53 | filing |
| 21 May 2026filed 26 May 2026 | CB ChubbInsurance | SEC FORM 4 Code A | —681 | filing |
| 21 May 2026filed 26 May 2026 | CB ChubbInsurance | SEC FORM 4 Code F | $64K193 at $330.26 | filing |
| 21 May 2026filed 26 May 2026 | CB ChubbInsurance | SEC FORM 4 Sold | $190K578 at $329.53 | filing |
| 16 Jun 2025filed 18 Jun 2025 | CB ChubbInsurance | SEC FORM 4 Sold | $155K538 at $287.56 | filing |
| 15 May 2025filed 16 May 2025 | CB ChubbInsurance | SEC FORM 4 Code A | —771 | filing |
| 15 May 2025filed 16 May 2025 | CB ChubbInsurance | SEC FORM 4 Code F | $53K180 at $292.05 | filing |
| 3 Sep 2024filed 5 Sep 2024 | CB ChubbInsurance | SEC FORM 4 Sold | $75K261 at $287.49 | filing |
| 17 May 2024filed 20 May 2024 | CB ChubbInsurance | SEC FORM 4 Sold | $193K716 at $269.70 | filing |
| 16 May 2024filed 17 May 2024 | CB ChubbInsurance | SEC FORM 4 Code A | —718 | filing |
| 16 May 2024filed 17 May 2024 | CB ChubbInsurance | SEC FORM 4 Code F | $63K239 at $264.88 | filing |
| 28 Jul 2023filed 14 Aug 2023 | CB ChubbInsurance | SEC FORM 4 Sold | $156K750 at $208.39 | filing |
| 17 May 2023filed 19 May 2023 | CB ChubbInsurance | SEC FORM 4 Code A | —955 | filing |
| 17 May 2023filed 19 May 2023 | CB ChubbInsurance | SEC FORM 4 Code F | $46K233 at $198.93 | filing |
| 3 Jan 2023filed 4 Jan 2023 | Oyster Point Pharmaoption or derivative | SEC FORM 4 Code D | —5,359 | filing |
| 3 Jan 2023filed 4 Jan 2023 | Oyster Point Pharmaoption or derivative | SEC FORM 4 Code D | —5,199 | filing |
News
Chubb Limited $CB Shares Acquired by Robertson Stephens Wealth Management LLCCB · dailypolitical.com · 18 Oct 2026Chubb Wealth and Hamilton Lane Form Partnership to Expand Access to Private Markets in Hong KongCB · manilatimes.net · 12 Oct 2026Chubb (CB) vs. Travelers (TRV): Which P&C Insurance Giant Is the Better Buy?CB · insidermonkey.com · 12 Oct 2026
0 headlines in the last 90 days name Michael G. Atieh; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.